Novo Nordisk Faces Crosswinds: EU Approvals and Heart Data Offset Brazil Generic Threat and Pricing
Novo Nordisk stock near €38 as Brazil OKs generic Ozempic, EU clears 2 Wegovy variants, CV study shows…
How Denmark’s Election Could Reshape Ørsted’s Future
Denmark’s election could force a sale of the state’s 50.1% stake in Ørsted, adding political risk as the…
Political Crosswinds Challenge Ørsted’s Recovery Momentum
Ørsted posts robust 2025 financials as Denmark’s election sparks debate on selling the state’s controlling stake, following a…
Political Crosswinds Challenge Ørsted’s Recovery Momentum
Ørsted posts robust 2025 financials as Denmark’s election sparks debate on selling the state’s controlling stake, following a…
How Denmark’s Election Could Reshape Ørsted’s Future
Denmark’s election could force a sale of the state’s 50.1% stake in Ørsted, adding political risk as the…